|
|
|
||
The subject presents the particular periods of the drug discovery process from searching for active structures to clinical testing. It describes the basic stages of a drug's life inside the organism (the LADME model) and relationships between its structure and activity (QSAR). The drug's physical-chemical properties and their parameterisation are also discussed.
Last update: TAJ111 (30.08.2013)
|
|
||
Students will be able to:
Last update: TAJ111 (30.08.2013)
|
|
||
Studenti musí vypracovat zadanou zápočtovou práci a napsat zkouškový test na více než 50 % bodů. Last update: Zbytovská Jarmila (25.02.2018)
|
|
||
R: Kuchař M.: Výzkum a vývoj léčiv. Vydavatelství VŠCHT Praha, 2008. ISBN 978-80-7080-677-7 A: Tsaioun K., Kates S.: ADMET for Medicinal Chemists: A Practical Guide. Wiley 2011. ISBN 978-0470484074 A: Hartl J., Palát K.: Farmaceutická chemie I. Karolinum 2011. ISBN 978-80-246-2033-6 A: Smith D. van den Waterbeemd H., Walker D.: Pharmacokinetics and metabolism in drug design. Wiley 2006. ISBN 3-527-31368 Last update: TAJ111 (30.08.2013)
|
|
||
1. Relationships between structure and biological activity of drugs, historical view, basic principles. 2. The particular periods of the drug discovery process, preclinical and clinical testing. 3. Current trends in drug discovery, biotechnology, management of drug research and development. 4. Development of generic drugs, relationships between original and generic companies. 5. The LADME model, pharmacokinetics. 6. Intramolecular interactions, drugs´ physical-chemical properties and their parametrization. 7. Electron parameters, Hammett polar constants, molar refraction. 8. Lipophilic parameters, fragment constants, substituent parameters, chromatographic values and lipophilicity. 9. Molecular topology, connectivity and flexibility indices. 10. Interpretation of regression relationships, dependent and independent variables, collienarity of parameters, selection of structure changes. 11. Practical impacts of QSAR. 12. Relationships between chirality and biological activity. 13. Current QSAR approaches, the CoMFA method, similarity models, lead structures identification, molecular modelling. 14. Economic issues of drug research and development, minimization of risk factors. Last update: TAJ111 (30.08.2013)
|
|
||
Learning materials distributed by lecturer Last update: TAJ111 (30.08.2013)
|
|
||
Pharmacology I, Introduction into Chemistry of Pharmaceuticals Last update: TAJ111 (30.08.2013)
|
Teaching methods | ||||
Activity | Credits | Hours | ||
Účast na přednáškách | 1 | 28 | ||
Příprava na přednášky, semináře, laboratoře, exkurzi nebo praxi | 1 | 28 | ||
Příprava na zkoušku a její absolvování | 1 | 28 | ||
3 / 3 | 84 / 84 |
Coursework assessment | |
Form | Significance |
Regular attendance | 20 |
Examination test | 80 |